Zydus Lifesciences Limited (ZYDUSLIFE.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 876.59B |
| Enterprise Value | 987.39B |
| P/E Ratio | 22.58 |
| PEG Ratio | 1.98 |
| Price/Sales Ratio | 4.16 |
| Price/Book Ratio | 4.2 |
| Enterprise/Revenue | 4.56 |
| Enterprise/EBITDA | 15.05 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.19 |
| Operating Margin | 0.29 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 271.48B |
| Revenue/Share | 269.88 |
| Gross Profit | 140.3B |
| EBITDA | 85.65B |
| Net Income | 50.4B |
| Diluted EPS | 50.09 |
Balance Sheet
| Total Cash | 71.92B |
| Total Cash/Share | 71.5 |
| Total Debt | 124.96B |
| Total Debt/Equity | 0.46 |
| Current Ratio | 1.27 |
| Book Value Per Share | 294.08 |
Price History
| 52-Week Change | 16.82 |
| 52-Week High | 1,181.5 |
| 52-Week Low | 835.5 |
| Moving Average 50 Days | 1,062.58 |
| Moving Average 200 Days | 957.22 |
Statistics
| Average Volume | 1.61M |
| Shares Outstanding | 997.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 11 |
| Trailing Annual Dividend Yield | 0.97 |
| Payout Ratio | 0.22 |
| Last Split Factor | 5:1 |
| Last Split Date | October 06, 2015 |
AD
